Markets are down as investors eagerly await the, results of the Federal Reserve's latest meeting, hoping for another round of quantitative easing. Meanwhile earnings have one Dow component surging ahead, while a small tech company is cut nearly in half after cutting guidance. Get today's big stories by watching the video
If you're tired of getting caught up in the daily action and looking for some long-term investing ideas, let us invite you to read the Fool's brand-new special report: "The 3 Dow Stocks Dividend Investors Need." It's absolutely free, so just click here and get your copy today.
David Williamson owns shares of Pfizer, but he holds no other position in any company mentioned. Click here to see his holdings and a short bio. Motley Fool newsletter services have recommended buying shares of Pfizer. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days. The Motley Fool has a disclosure policy.